lobbying_activities: 2110026

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2110026	64bb230d-b100-4ce8-9e83-e13296a82c9f	Q1	WINNING STRATEGIES WASHINGTON	50796	KALEO	2018	first_quarter	PHA	Pharmaceutical drug development including epinephrine for anaphylaxis	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE	40000		0	0	2018-04-18T11:58:11.280000-04:00